In vitro studies have revealed that TGF-β1 enhances the migratory capacity of various osteosarcoma cell lines, a phenomenon likely linked to its ability to induce epithelial–mesenchymal transition (EMT)-like changes. Here, TGFB1 is linked to osteosarcoma.